Novel evidence has suggested that the inhibition of miR-223-3p expression could upregulate the expression of FOXO3 and activate the autophagy pathway, thereby significantly inhibiting myocardial fibrosis and improving myocardial remodeling in AF (22). This evidence concerns the gene FOXO3 and Myocardial fibrosis.